More
    HomeHealthA drug against blindness sold 850,000 dollars in the United States

    A drug against blindness sold 850,000 dollars in the United States

    Luxturna, a medicine against hereditary degeneration of the retina that can progress to total blindness, will be sold for $ 850,000 in the United States, making it one of the most expensive treatments in the world.

    Luxturna

    Luxturna is one of the most expensive medicines in the world.

    Luxturna, a medicine against hereditary degeneration of the retina that can progress to total blindness, will be sold for $ 850,000 in the United States, making it one of the most expensive treatments in the world.

    It is administered in a single dose, said its manufacturer, the biotechnology company Spark Therapeutics, based in Philadelphia (east).

    In detail, it will cost $ 425,000 per eye but the final price remains below $ 1 million initially considered when it received clearance from the US Drug Agency (FDA) mid-December.

    luxturna

    This announcement comes in full debate on the high price of drugs in the United States, including the so-called innovative treatment prices, and should not fail to raise protests.

    In anticipation of criticism, Spark promised to reimburse the patients if the treatment was not effective and also plans to ask the health authorities to authorize a payment in stages.

    Biotech is inspired by a recent approach adopted by the Swiss laboratory Novartis at the beginning of the commercialization of Kymriah , supposed to treat a very aggressive form of leukemia in children and young adults. The Swiss laboratory is committed to return the money to insurers and patients in case of inefficiency of this treatment, sold 475,000 dollars.

    Luxturna is considered the first gene therapy-based American medicine to correct a genetic defect by repairing the defective gene. About 1,000 cases of people suffering from hereditary degeneration of the retina are currently in the United States and 10 to 20 new cases are expected per year in the coming years.

    In addition to Luxturna, other drugs are around $ 1 million right now, although they often require several doses.

    This is the case of Spinraza  (Nusinersen in Europe), developed by Biogen and Ionis Pharmaceuticals against muscle atrophy, and Soliris, manufactured by Alexion Pharmaceuticals to treat a rare kidney disease. They both cost about $ 750,000.

    The most expensive drug in the world, however, comes to Glybera , the first gene drug sold 1 million dollars by the Dutch group UniQure to cure several genetic diseases.

    Related news

    WP Radio
    WP Radio
    OFFLINE LIVE